PAVmed Future Growth
Future criteria checks 2/6
PAVmed is forecast to grow earnings and revenue by 20.3% and 47.2% per annum respectively while EPS is expected to grow by 65.4% per annum.
Key information
20.3%
Earnings growth rate
65.4%
EPS growth rate
| Medical Equipment earnings growth | 16.2% |
| Revenue growth rate | 47.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 14 Apr 2024 |
Recent future growth updates
Recent updates
Are Investors Undervaluing PAVmed Inc. (NASDAQ:PAVM) By 28%?
Jan 29
Is PAVmed (NASDAQ:PAVM) Using Debt In A Risky Way?
Aug 17PAVmed Non-GAAP EPS of -$0.17 beats by $0.03
Aug 16PAVmed Continues To Have Lots Of Potential But EsoGuard Determines Short-Term Progress
Jul 05Start Accumulating PAVmed
Dec 24We Think PAVmed (NASDAQ:PAVM) Can Afford To Drive Business Growth
Sep 02PAVmed: Long Term Investment Case Remains Despite Weak Q2
Aug 23PAVmed: A True Game-Changer For Medical Device Innovation
Jun 14PAVmed forms digital health company, Veris Health
Jun 02PAVmed's subsidiary receives CE mark for EsoCheck esophageal cell collection device
May 26PAVmed (NASDAQ:PAVM) Is In A Good Position To Deliver On Growth Plans
May 19PAVmed drops 14% on launch of $13.4M direct offering
Jan 06PAVmed closes additional direct offering of common stock
Dec 22Do Institutions Own PAVmed Inc. (NASDAQ:PAVM) Shares?
Dec 16PAVmed offers stock for $8.9M
Dec 11PAVmed EPS beats by $0.02
Nov 17There Is Progress At PAVmed, But More Patience Is Required
Oct 30Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 101 | -19 | -3 | N/A | 1 |
| 12/31/2025 | 18 | -59 | -41 | -47 | 3 |
| 12/31/2024 | 6 | -61 | -60 | -49 | 4 |
| 12/31/2023 | 2 | -66 | -52 | -52 | N/A |
| 9/30/2023 | 2 | -71 | -57 | -57 | N/A |
| 6/30/2023 | 1 | -79 | -69 | -65 | N/A |
| 3/31/2023 | 1 | -90 | -79 | -75 | N/A |
| 12/31/2022 | 0 | -89 | -76 | -71 | N/A |
| 9/30/2022 | 1 | -86 | -79 | -71 | N/A |
| 6/30/2022 | 1 | -72 | -64 | -60 | N/A |
| 3/31/2022 | 1 | -58 | -48 | -44 | N/A |
| 12/31/2021 | 1 | -51 | -44 | -41 | N/A |
| 9/30/2021 | 0 | -42 | -31 | -31 | N/A |
| 6/30/2021 | N/A | -35 | -29 | -28 | N/A |
| 3/31/2021 | N/A | -30 | -27 | -27 | N/A |
| 12/31/2020 | N/A | -35 | -22 | -22 | N/A |
| 9/30/2020 | N/A | -32 | -19 | -19 | N/A |
| 6/30/2020 | N/A | -30 | -16 | -16 | N/A |
| 3/31/2020 | N/A | -28 | -13 | -13 | N/A |
| 12/31/2019 | N/A | -17 | -13 | -13 | N/A |
| 9/30/2019 | N/A | -17 | -12 | -12 | N/A |
| 6/30/2019 | N/A | -17 | -11 | -11 | N/A |
| 3/31/2019 | N/A | -19 | -10 | -10 | N/A |
| 12/31/2018 | N/A | -19 | -9 | -9 | N/A |
| 9/30/2018 | N/A | -12 | -7 | -7 | N/A |
| 6/30/2018 | N/A | -14 | -8 | -8 | N/A |
| 3/31/2018 | N/A | -10 | -7 | -7 | N/A |
| 12/31/2017 | N/A | -10 | -7 | -7 | N/A |
| 9/30/2017 | N/A | -12 | N/A | -6 | N/A |
| 6/30/2017 | N/A | -9 | N/A | -5 | N/A |
| 3/31/2017 | N/A | -9 | N/A | -6 | N/A |
| 12/31/2016 | N/A | -6 | N/A | -4 | N/A |
| 9/30/2016 | N/A | -5 | N/A | -4 | N/A |
| 6/30/2016 | N/A | -3 | N/A | -3 | N/A |
| 3/31/2016 | N/A | -2 | N/A | -2 | N/A |
| 12/31/2015 | N/A | -2 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PAVM is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PAVM is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PAVM is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: PAVM's revenue (47.2% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: PAVM's revenue (47.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PAVM's Return on Equity is forecast to be high in 3 years time